NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NEO NeoGenomics

交易中 02-11 11:54:49 EST

11.26

-0.24

-2.09%

最高11.58	最低11.12	成交量53.73万
今开11.58	昨收11.50	日振幅4.00%
总市值14.57亿	流通市值13.51亿	总股本1.29亿
成交额605.92万	换手率0.45%	流通股本1.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NEO","market":"US","secType":"STK","nameCN":"NeoGenomics","latestPrice":11.26,"timestamp":1770828867520,"preClose":11.5,"halted":0,"volume":537291,"delay":0,"changeRate":-0.020869565217391323,"floatShares":119990456,"shares":129387801,"eps":-0.890791,"marketStatus":"交易中","change":-0.24,"latestTime":"02-11 11:54:49 EST","open":11.58,"high":11.58,"low":11.12,"amount":6059196.092627999,"amplitude":0.04,"askPrice":11.27,"askSize":114,"bidPrice":11.25,"bidSize":237,"shortable":3,"etf":0,"ttmEps":-0.890791,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1355115600000,"exchange":"NASDAQ","adjPreClose":11.5,"preHourTrading":{"tag":"盘前","latestPrice":11.77,"preClose":11.5,"latestTime":"09:24 EST","volume":136144,"amount":1568701.813568,"timestamp":1770819899330,"change":0.27,"changeRate":0.023478,"amplitude":0.06},"postHourTrading":{"tag":"盘后","latestPrice":11.5,"preClose":11.5,"latestTime":"19:17 EST","volume":37695,"amount":433505.94,"timestamp":1770769079058,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8906,"impliedVol":0.5048,"impliedVolPercentile":0.3466},"requestUrl":"/m/hq/s/NEO/wiki","defaultTab":"wiki","newsList":[{"id":"1103569518","title":"NeoGenomics任命诊断与实验室服务行业资深专家John P. \"Jack\" Kenny加入董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=1103569518","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103569518?lang=zh_cn&edition=full","pubTime":"2025-12-30 20:09","pubTimestamp":1767096559,"startTime":"0","endTime":"0","summary":"NeoGenomics宣布，正式委任诊断及实验室服务领域的资深人士John P. \"Jack\" Kenny为公司董事会成员。Kenny在相关行业拥有丰富的从业经验，此次任命有望为公司的战略发展注入新的专业视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0106261612.USD","NEO","BK4196","LU0012050646.USD"],"gpt_icon":0},{"id":"1108326739","title":"NeoGenomics公司 - 正在推进其Radar ST分子残留病（MRD）检测在2026年第一季度的全面美国临床发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1108326739","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108326739?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:07","pubTimestamp":1765800424,"startTime":"0","endTime":"0","summary":"NeoGenomics公司 - 正在推进其Radar ST分子残留病（MRD）检测在2026年第一季度的全面美国临床发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO","BK4196","LU0106261612.USD","BK4121","LU0012050646.USD"],"gpt_icon":0},{"id":"1135552404","title":"NeoGenomics宣布Natera自愿撤回在Radar专利诉讼中的上诉","url":"https://stock-news.laohu8.com/highlight/detail?id=1135552404","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135552404?lang=zh_cn&edition=full","pubTime":"2025-12-15 20:05","pubTimestamp":1765800342,"startTime":"0","endTime":"0","summary":"NeoGenomics宣布Natera自愿撤回在Radar专利诉讼中的上诉","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU0106261612.USD","BK4121","NEO","LU0012050646.USD"],"gpt_icon":0},{"id":"2589835610","title":"道达尔能源上游业务与NEO NEXT将合并，成英国最大独立油气生产商","url":"https://stock-news.laohu8.com/highlight/detail?id=2589835610","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589835610?lang=zh_cn&edition=full","pubTime":"2025-12-08 22:04","pubTimestamp":1765202698,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4196","BK4201","LU0012050646.USD","BK4588","LU2129689431.USD","LU2237443549.SGD","NEO","LU2129689514.USD","BK4144","LU2237443465.HKD","BK4561","LU0106261612.USD","BK4585","LU2237443978.SGD","159945","LU2237443382.USD","TTE","BK4121","LU2237443895.HKD","LU2129689605.HKD","NEXT","LU2237443622.USD"],"gpt_icon":0},{"id":"2588062430","title":"商汤(00020)涨3.38% 发布及开源全新多模态模型架构“NEO”","url":"https://stock-news.laohu8.com/highlight/detail?id=2588062430","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588062430?lang=zh_cn&edition=full","pubTime":"2025-12-04 15:08","pubTimestamp":1764832084,"startTime":"0","endTime":"0","summary":"金吾财讯 | 商汤(00020)午后股价维持高位，截至发稿，涨3.38%，报2.14港元，成交额6.44亿港元。公司日前宣布正式发布及开源与南洋理工大学S-Lab合作研发的全新多模态模型架构“NEO”，预期是行业首个可用的、实现深层次融合的原生多模态架构(Native VLM)，通过从底层原理出发，以“专为多模态而生”的创新设计，在核心架构层面进行多模态深层融合，实现性能、效率和通用性的整体突破，为日日新SenseNova多模态模型奠定新架构基础，并标志着AI多模态技术迈入“原生架构”的新时代。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1613","BK4121","00020","BK4196","BK1109","80020","BK1615","LU0012050646.USD","LU0106261612.USD","NEO"],"gpt_icon":0},{"id":"1149199189","title":"NeoGenomics专利诉讼胜利对股价构成利好 -- 市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1149199189","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1149199189?lang=zh_cn&edition=full","pubTime":"2025-08-30 01:38","pubTimestamp":1756489116,"startTime":"0","endTime":"0","summary":"NeoGenomics在与Natera的专利侵权诉讼中获得简易判决胜利，消除了股票面临的部分诉讼阻力，为股价提供了催化剂，Benchmark分析师Bruce Jackson在研究报告中表示。得益于这一裁决，这家癌症检测公司将能够继续在美国制造、使用、销售和推广其RaDaR ST分子残留疾病检测法。\n另一方面，Natera表示正在评估其选择，包括上诉以及通过其他专利进一步执法。NeoGenomics股价大涨24%，而Natera股价基本持平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTRA","LU2065731478.USD","LU2065171402.SGD","BK4139","LU2264538146.SGD","LU2324357040.USD","LU0106261612.USD","LU0012050646.USD","LU0963586101.USD","LU0053671581.USD","LU1064131342.USD","LU2065169927.USD","NEO","BK4196","BK4121","LU2065170008.USD","LU0345770308.USD","LU2065171311.SGD","LU1988902786.USD","LU0345770993.USD"],"gpt_icon":0},{"id":"2560744929","title":"Binance下架NeoLegacy网络代币充值、提现业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2560744929","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560744929?lang=zh_cn&edition=full","pubTime":"2025-08-18 15:02","pubTimestamp":1755500530,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.binance.com/zh-CN/support/announcement/detail/de7a6d49a1fc4153b2c7d82babc6033f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["LU0012050646.USD","BK4121","LU0106261612.USD","BK4196","NEO"],"gpt_icon":0},{"id":"2560897401","title":"Binance 下架 Neo Legacy 网络代币充值、提现业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2560897401","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560897401?lang=zh_cn&edition=full","pubTime":"2025-08-18 15:00","pubTimestamp":1755500459,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Binance 将于 2025 年 8 月 25 日 16:00 停止支持 Neo Legacy 网络的充值业务，2025 年 10 月 15 日 16:00 停止所有代币的提现业务。用户仍可通过币安支持的其他网络充值或提现 NEO（NEO）和 NeoGas（GAS），请及时处理相关资产。 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2198258","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","LU0106261612.USD","NEO","LU0012050646.USD","BK4196"],"gpt_icon":0},{"id":"2518439713","title":"光线传媒12.2亿收购奥林NEO项目，东方资产、翰同资本成功退出","url":"https://stock-news.laohu8.com/highlight/detail?id=2518439713","media":"微博财经-财道工作室","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518439713?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:38","pubTimestamp":1741682280,"startTime":"0","endTime":"0","summary":"光线传媒近日公告计划斥资12.2亿元收购北京奥林NEO办公楼，交易对手为东方资产、翰同资本等。尽管当前办公楼市场面临一定空置率压力，但光线传媒对奥林NEO项目的升值空间仍表达了乐观态度。本次出售奥林NEO有助于东方资产进一步改善资产流动性，加快投资收益落袋。今年2月，东方资产公告控股股东变更为中央汇金公司。此次光线传媒承债式收购奥林NEO，意味着大连银行的信贷资金将得到保证。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-03-11/doc-inephnhf9666802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0049","BK4196","BK0087","LU0106261612.USD","NEO","BK0267","BK0083","BK0098","LU0012050646.USD","BK4121","BK0108","300251","BK0188","BK0200"],"gpt_icon":0},{"id":"2518879284","title":"《哪咤2》爆火后 光线传媒12.2亿收购北京奥林NEO办公楼","url":"https://stock-news.laohu8.com/highlight/detail?id=2518879284","media":"观点网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518879284?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:25","pubTimestamp":1741537512,"startTime":"0","endTime":"0","summary":"3月7日晚，光线传媒发布购买资产公告，宣布将斥资12.2亿元购买北京棫霖企业管理有限公司100%股权，从而取得位于北京市朝阳区的北京奥林NEO大楼作为办公场所。根据公司2024年三季报显示，光线传媒期内营业收入仅有14.42亿元，归母净利润为4.61亿元，扣非归母净利润为4.33亿元。也就是说，光线传媒实质上是买下了北京奥林NEO这座办公楼。根据公司披露的交易公告，光线传媒此次收购奥林NEO项目所涉及的全部款项合计人民币12.20亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10002548615300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0083","BK4121","BK0087","LU0012050646.USD","NEO","BK0200","BK0108","300251","BK4196","LU0106261612.USD","BK0049","BK0267","BK0188","BK0098"],"gpt_icon":0},{"id":"2514029642","title":"券商晨会精华 | NEO Gamma人形机器人发布 新材料应用迎催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029642","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514029642?lang=zh_cn&edition=full","pubTime":"2025-02-26 08:24","pubTimestamp":1740529470,"startTime":"0","endTime":"0","summary":"银河证券表示，机场板块层面，当前机场板块对于免税协议重签扣点率下降的悲观情绪基本已被priced in。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4121","LU0106261612.USD","NEO","BK4196","LU0012050646.USD","159703"],"gpt_icon":0},{"id":"1121407072","title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1121407072","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121407072?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:24","pubTimestamp":1739982268,"startTime":"0","endTime":"0","summary":"NeoGenomics(NEO)公司今日盘中股价大涨5.20%,引发市场关注。\n分析人士指出,这很可能与华尔街分析师看好该公司前景有关。路透社报道,杰富瑞(JEF)分析师将NeoGenomics的目标价从22美元下调至18美元,反映出分析师仍然对该公司持相对乐观态度。\nNeoGenomics是一家癌症诊断和生物疗法公司,行业前景广阔。虽然面临诸多不确定性,但有分析师维持中性评级并上调目标价,表明公司业务仍备受看好。投资者对NeoGenomics长期增长前景持乐观态度,推动其盘中大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NEO"],"gpt_icon":0},{"id":"2512848814","title":"Neogenomics, Inc.盘中异动 早盘急速拉升5.12%报13.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848814?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:22","pubTimestamp":1739982152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时22分，Neogenomics, Inc.股票出现波动，股价大幅拉升5.12%。截至发稿，该股报13.04美元/股，成交量55.049万股，换手率0.43%，振幅9.83%。Neogenomics, Inc.股票所在的生命科学行业中，整体涨幅为0.87%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU0106261612.USD","NEO","BK4196","LU0012050646.USD"],"gpt_icon":0},{"id":"2512102631","title":"B of A Securities：维持NeoGenomics(NEO.US)评级，由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512102631","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512102631?lang=zh_cn&edition=full","pubTime":"2025-02-19 21:21","pubTimestamp":1739971312,"startTime":"0","endTime":"0","summary":"B of A Securities：维持NeoGenomics(NEO.US)评级，由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19212148266507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NEO"],"gpt_icon":0},{"id":"2512165115","title":"Neogenomics, Inc.盘中异动 早盘股价大跌10.61%报12.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165115?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889091,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Neogenomics, Inc.股票出现异动，股价大幅跳水10.61%。Neogenomics, Inc.股票所在的生命科学行业中，整体跌幅为0.03%。其相关个股中，Genedx Holdings Corp.、Prophase Labs, Inc.、燃石医学涨幅较大，Prophase Labs, Inc.、Check-Cap Ltd.、Mainz Biomed N.V.较为活跃，换手率分别为61.77%、1.36%、0.79%，振幅较大的相关个股有Grail, Inc.、Neogenomics, Inc.、Twist Bioscience Corporation，振幅分别为4.34%、2.59%、2.45%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223131a24aac74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223131a24aac74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0012050646.USD","BK4196","LU0106261612.USD","NEO","BK4121"],"gpt_icon":0},{"id":"1166373264","title":"异动解读 | NeoGenomics每股收益大超预期,股价盘前大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166373264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166373264?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:10","pubTimestamp":1739880615,"startTime":"0","endTime":"0","summary":"NeoGenomics公司(股票代码:NEO)2025年2月18日周二盘前股价大涨5.06%,引发了投资者的广泛关注。\n\n据悉,NeoGenomics公司2024年第四季度财报数据优于预期,尤其是公司每股收益远高于分析师的预期,这可能是导致该公司股价大涨的主要原因。\n\n公司2024年第四季度实现调整后每股收益0.04美元,高于分析师一致预期的0.03美元,环比增长33.33%。而公司当季度销售额虽然小幅低于预期,但仍同比增长10.57%,达到1.72亿美元。盈利数据的优异表现令市场对该公司的发展前景看好,带动了公司股价在盘前大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NEO"],"gpt_icon":0},{"id":"1123802248","title":"NeoGenomics 2024年第四季度调整后每股收益$0.04，超出预期的$0.03，销售额为$1.72亿，不及预期的$1.7318亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1123802248","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123802248?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:06","pubTimestamp":1739880403,"startTime":"0","endTime":"0","summary":"NeoGenomics报告季度每股收益为0.04美元，高于分析师一致预期的0.03美元，超出33.33%。公司报告季度销售额为1.72亿美元，低于分析师一致预期的1.7318亿美元，低出0.68%。这比去年同期的销售额1.5555亿美元增加了10.57%。以上内容来自Benzinga Earnings专栏，原文如下：$NeoGenomics$  reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year.  The company reported quarterly sales of $172.00 million which missed the analyst consensus estimate of $173.18 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NeoGenomics 2024年第四季度调整后每股收益$0.04，超出预期的$0.03，销售额为$1.72亿，不及预期的$1.7318亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO"],"gpt_icon":1},{"id":"2511195692","title":"Neogenomics, Inc.盘中异动 早盘股价大涨5.02%报14.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511195692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511195692?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:53","pubTimestamp":1739548406,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时53分，Neogenomics, Inc.股票出现波动，股价急速上涨5.02%。截至发稿，该股报14.61美元/股，成交量18.216万股，换手率0.14%，振幅4.67%。Neogenomics, Inc.股票所在的生命科学行业中，整体涨幅为0.79%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423532798859ce5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423532798859ce5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4196","LU0012050646.USD","LU0106261612.USD","NEO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neogenomics.com","stockEarnings":[{"period":"1week","weight":-0.08},{"period":"1month","weight":-0.1261},{"period":"3month","weight":0.15},{"period":"6month","weight":0.8548},{"period":"1year","weight":-0.1488},{"period":"ytd","weight":-0.0221}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neogenomics, Inc.于1988年10月29日在内华达州注册成立。该公司专门从事癌症遗传学测试和信息服务，为医生提供世界上最全面的以肿瘤为中心的测试菜单之一，帮助他们诊断和治疗癌症。公司的药物服务部为制药客户提供临床试验和药物开发服务。1998年10月29日，母公司作为美国通信企业有限公司在内华达州注册成立，母公司在2001年12月14日更名为Neogenomics, Inc.。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.004357},{"month":2,"riseRate":0.5,"avgChangeRate":0.021953},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.02259},{"month":4,"riseRate":0.307692,"avgChangeRate":-0.045081},{"month":5,"riseRate":0.615385,"avgChangeRate":0.039399},{"month":6,"riseRate":0.692308,"avgChangeRate":0.039643},{"month":7,"riseRate":0.846154,"avgChangeRate":0.095096},{"month":8,"riseRate":0.461538,"avgChangeRate":0.036189},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.023669},{"month":10,"riseRate":0.615385,"avgChangeRate":0.070403},{"month":11,"riseRate":0.692308,"avgChangeRate":0.100243},{"month":12,"riseRate":0.230769,"avgChangeRate":-0.03319}],"exchange":"NASDAQ","name":"NeoGenomics","nameEN":"NeoGenomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeoGenomics,NEO,NeoGenomics股票,NeoGenomics股票老虎,NeoGenomics股票老虎国际,NeoGenomics行情,NeoGenomics股票行情,NeoGenomics股价,NeoGenomics股市,NeoGenomics股票价格,NeoGenomics股票交易,NeoGenomics股票购买,NeoGenomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}